Drug Interactions Workshop

Registration
Session Description
Case Authors and Reviewers
Workshop Facilitators and Manual Creators
Learning Objectives
Accreditation

The Drug Interactions Workshop will be held on Thursday, April 25, 2019 from 12:00 to 17:00 in conjunction with the CAPhO Conference 2019.

In small groups, you will work through drug interaction cases with the support of expert facilitators. The cases will be typical of clinically relevant drug interactions you will encounter in oncology pharmacy practice. You and your group will make a series of decisions including interpretation of the drug interaction resource information, development of a pharmaceutical care plan including a recommendation, clinical rationale, communication of your plan, and creation of a patient follow up and/or monitoring plan.

Registration

Registration Fees

Workshop registration is open to CAPhO members and non-members. Registration fees are listed below. Fees are quoted in Canadian Dollars (CAD) and exclude 5% Goods and Services Tax (GST). Early Bird rates are available until Monday, March 14, 2019. Registrants who pay their registration fee after Monday, March 4, 2019 will be charged the regular registration fee.

  Early Bird Until March 4, 2019 Regular as of March 5, 2019
CAPhO Member $49 $99
Non-Member $149 $199

 

CAPhO Member registration fees are available to those who have paid their 2018 and renewed their 2019 CAPhO membership. CAPhO Member registrations will be verified and the difference will be charged if a registrant does not qualify for the member's rate.

Register Now (Not yet live)

Visit the CAPhO 2019 Registration page to register now and for information on the cancellation, refund and substitution policy, methods of payment and other important registration details.

Session Descriptions

Coming soon

 

Case Authors and Reviewers

Coming soon

Back to top

Workshop Facilitators and Manual Creators

Coming soon

 

Workshop Learning Objectives

  • Assessing patient information and evaluating drug interaction resource materials to identify and prioritize drug interactions commonly seen in oncology practice.
  • Integrating critical thinking and “shared decision making” into drug interaction assessment to develop appropriate recommendations and create suitable monitoring plans.
  • Communicating drug interaction(s) with patients and/or care team providers.

Accreditation

The Drug Interactions Workshop will be seeking accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP). CCCEP is a national organization established to accredit continuing pharmacy education programs intended to be delivered to pharmacy professionals from more than one province or nationally. CCCEP accreditation is recognized by the pharmacy regulatory authorities in all provinces and territories of Canada.